Abstract Title:

Amygdalin decreases adhesion and migration of MDA-MB-231 and MCF-7 breast cancer cell lines.

Abstract Source:

Curr Mol Pharmacol. 2020 Aug 10. Epub 2020 Aug 10. PMID: 32778045

Abstract Author(s):

Bashir Mosayyebi, Leila Mohammadi, Ashkan Kalantary-Charvadeh, Mohammad Rahmati

Article Affiliation:

Bashir Mosayyebi


BACKGROUND: Cell adhesion as dynamic interactions between cell-cell and cell-matrix, has an essential role in cancer cell migration. Integrins as cell membrane receptors are involved in cell adhesion and signal transduction. Aberrant expression of integrins is associated with the cancer cell adhesion.

OBJECTIVE: Targeting the process of cell adhesion and migration could be helpful to prevent cancer cell metastasis. Amygdalin is a cyanoglycoside compound with anti-cancer properties, while its effect on cancer cell adhesion is not completely clear.

METHODS: The cytotoxic effect of amygdalin on breast cancer cell lines (MCF-7 and MDA-MB-231) and human skin fibroblast cell line as a normal cell, was evaluated through MTT assay. The cell adhesion assay and wound healing assay were performed to determine amygdalin effects on adhesion and migration of cancer cells. Further analysis was carried out to evaluate integrinα and β levels through real-time PCR.

RESULTS: We demonstrated that amygdalin diminished the cell viability of both cell lines in a time and dose-dependent manner, while amygdalin did not have any toxicity on human skin fibroblast cell line in same dosages. Following amygdalin treatment, the adhesion of both studied cell lines to fibronectin and collagen I decrease, and this reduction is significantly greater in the case of binding to fibronectin compared to binding to collagen. The MDA-MB-231 cell migration was decreased greater than MCF-7 cells. The levels ofα and β integrin were differentially regulated by amygdalin in both cancer cell lines.

CONCLUSION: These results suggest that depending on cancer cell lines, amygdalin affects cancer cell adhesion and migration.

Study Type : In Vitro Study

Print Options

Key Research Topics

Sayer Ji
Founder of GreenMedInfo.com

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.

Download Now

500+ pages of Natural Medicine Alternatives and Information.

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2022 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.